DexCom had 15 patents in artificial intelligence during Q1 2024. DexCom Inc’s patents filed in Q1 2024 focus on providing personalized smart alerts for diabetic users, optimizing communication delivery through cohort selection criteria, and detecting end of life for continuous analyte sensors based on various risk factors. These systems and methods aim to improve user experience and accuracy in managing diabetes. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom grant share with artificial intelligence as a theme is 26% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: System and method for providing alerts optimized for a user (Patent ID: US20240071593A1)
The patent filed by DexCom Inc. discloses systems and methods for providing personalized smart alerts to users regarding diabetic states only when necessary, based on predictions of the user's cognitive awareness of their condition. The alerts are designed to be effective and tailored to the individual user, ensuring that notifications are given only when corrective action is required, such as a bolus or basal rate change, and not when unnecessary, such as when the user is already aware of the situation or has taken corrective action.
The patent includes claims for a computer-readable medium containing instructions for dynamically reducing alerting of users to diabetic states, based on identifying atypical states, patterns, or trends in glucose concentration values. The system described in the patent involves a CGM application on a mobile device that receives data from a sensor and displays glucose concentration data, along with a smart alerts application within the CGM application that performs the method of providing personalized alerts based on the identified diabetic states warranting user attention. Overall, the patent aims to improve the management of diabetes by delivering timely and relevant alerts to users, enhancing their awareness and response to their condition.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
